118 related articles for article (PubMed ID: 20346058)
21. Epigallocatechin gallate elicits contractions of the isolated aorta of the aged spontaneously hypertensive rat.
Li Z; Wang Y; Vanhoutte PM
Basic Clin Pharmacol Toxicol; 2011 Jul; 109(1):47-55. PubMed ID: 21310006
[TBL] [Abstract][Full Text] [Related]
22. Palmitic acid exerts pro-inflammatory effects on vascular smooth muscle cells by inducing the expression of C-reactive protein, inducible nitric oxide synthase and tumor necrosis factor-α.
Wu D; Liu J; Pang X; Wang S; Zhao J; Zhang X; Feng L
Int J Mol Med; 2014 Dec; 34(6):1706-12. PubMed ID: 25242580
[TBL] [Abstract][Full Text] [Related]
23. The behavior of vascular smooth muscle cells and platelets onto epigallocatechin gallate-releasing poly(l-lactide-co-epsilon-caprolactone) as stent-coating materials.
Cho HH; Han DW; Matsumura K; Tsutsumi S; Hyon SH
Biomaterials; 2008 Mar; 29(7):884-93. PubMed ID: 18031806
[TBL] [Abstract][Full Text] [Related]
24. Aldosterone induces C-reactive protein expression via MR-ROS-MAPK-NF-κB signal pathway in rat vascular smooth muscle cells.
Zhang X; Liu J; Pang X; Zhao J; Wang S; Wu D
Mol Cell Endocrinol; 2014 Sep; 395(1-2):61-8. PubMed ID: 25109280
[TBL] [Abstract][Full Text] [Related]
25. Epigallocatechin-3-gallate inhibits proliferation of human aortic smooth muscle cells via up-regulating expression of mitofusin 2.
Shu Z; Yu M; Zeng G; Zhang X; Wu L; Tan X
Eur J Cell Biol; 2014 Apr; 93(4):137-44. PubMed ID: 24880525
[TBL] [Abstract][Full Text] [Related]
26. [Effects of oxidized-low density lipoprotein on expression of urotensin II receptor GPR14 in rat aortic smooth muscle cells].
Wang ZJ; Ding WH; Shi LB; Bu DF; Ren ZW; Tang CS
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(4):242-6. PubMed ID: 16677503
[TBL] [Abstract][Full Text] [Related]
27. The antioxidant (-)-epigallocatechin-3-gallate inhibits activated hepatic stellate cell growth and suppresses acetaldehyde-induced gene expression.
Chen A; Zhang L; Xu J; Tang J
Biochem J; 2002 Dec; 368(Pt 3):695-704. PubMed ID: 12223099
[TBL] [Abstract][Full Text] [Related]
28. Cardioprotective effects of epigallocatechin-3-gallate against doxorubicin-induced cardiomyocyte injury.
Zheng J; Lee HC; Bin Sattar MM; Huang Y; Bian JS
Eur J Pharmacol; 2011 Feb; 652(1-3):82-8. PubMed ID: 21114975
[TBL] [Abstract][Full Text] [Related]
29. Angiotensin II induces C-reactive protein expression through ERK1/2 and JNK signaling in human aortic endothelial cells.
Han C; Liu J; Liu X; Li M
Atherosclerosis; 2010 Sep; 212(1):206-12. PubMed ID: 20538278
[TBL] [Abstract][Full Text] [Related]
30. Possible role of antioxidative capacity of (-)-epigallocatechin-3-gallate treatment in morphological and neurobehavioral recovery after sciatic nerve crush injury.
Renno WM; Benov L; Khan KM
J Neurosurg Spine; 2017 Nov; 27(5):593-613. PubMed ID: 28777065
[TBL] [Abstract][Full Text] [Related]
31. Epigallocatechin-3-gallate augments antioxidant activities and inhibits inflammation during bleomycin-induced experimental pulmonary fibrosis through Nrf2-Keap1 signaling.
Sriram N; Kalayarasan S; Sudhandiran G
Pulm Pharmacol Ther; 2009 Jun; 22(3):221-36. PubMed ID: 19138753
[TBL] [Abstract][Full Text] [Related]
32. Epigallocatechin-3-gallate inhibits interleukin-1beta-induced expression of nitric oxide synthase and production of nitric oxide in human chondrocytes: suppression of nuclear factor kappaB activation by degradation of the inhibitor of nuclear factor kappaB.
Singh R; Ahmed S; Islam N; Goldberg VM; Haqqi TM
Arthritis Rheum; 2002 Aug; 46(8):2079-86. PubMed ID: 12209512
[TBL] [Abstract][Full Text] [Related]
33. C-reactive protein triggers inflammatory responses partly via TLR4/IRF3/NF-κB signaling pathway in rat vascular smooth muscle cells.
Liu N; Liu JT; Ji YY; Lu PP
Life Sci; 2010 Sep; 87(11-12):367-74. PubMed ID: 20670634
[TBL] [Abstract][Full Text] [Related]
34. Resveratrol inhibits angiotensin II-induced endothelin-1 gene expression and subsequent proliferation in rat aortic smooth muscle cells.
Chao HH; Juan SH; Liu JC; Yang HY; Yang E; Cheng TH; Shyu KG
Eur J Pharmacol; 2005 May; 515(1-3):1-9. PubMed ID: 15878161
[TBL] [Abstract][Full Text] [Related]
35. Atorvastatin decreases C-reactive protein-induced inflammatory response in pulmonary artery smooth muscle cells by inhibiting nuclear factor-kappaB pathway.
Li J; Li JJ; He JG; Nan JL; Guo YL; Xiong CM
Cardiovasc Ther; 2010; 28(1):8-14. PubMed ID: 20074254
[TBL] [Abstract][Full Text] [Related]
36. Development of epigallocatechin gallate-eluting polymeric stent and its physicochemical, biomechanical and biological evaluations.
Han DW; Lee JJ; Jung DY; Park JC; Hyon SH
Biomed Mater; 2009 Aug; 4(4):044104. PubMed ID: 19584425
[TBL] [Abstract][Full Text] [Related]
37. Selective inhibitory effect of epigallocatechin-3-gallate on migration of vascular smooth muscle cells.
Han DW; Lee MH; Kwon BJ; Kim HL; Hyon SH; Park JC
Molecules; 2010 Nov; 15(11):8488-500. PubMed ID: 21102375
[TBL] [Abstract][Full Text] [Related]
38. Modulation of collagen type I, fibronectin and dermal fibroblast function and activity, in systemic sclerosis by the antioxidant epigallocatechin-3-gallate.
Dooley A; Shi-Wen X; Aden N; Tranah T; Desai N; Denton CP; Abraham DJ; Bruckdorfer R
Rheumatology (Oxford); 2010 Nov; 49(11):2024-36. PubMed ID: 20627968
[TBL] [Abstract][Full Text] [Related]
39. Underlying mechanism for suppression of vascular smooth muscle cells by green tea polyphenol EGCG released from biodegradable polymers for stent application.
Han DW; Jung DY; Park JC; Cho HH; Hyon SH; Han DK
J Biomed Mater Res A; 2010 Nov; 95(2):424-33. PubMed ID: 20648542
[TBL] [Abstract][Full Text] [Related]
40. (-)-Epigallocatechin-3-gallate inhibits human papillomavirus (HPV)-16 oncoprotein-induced angiogenesis in non-small cell lung cancer cells by targeting HIF-1α.
He L; Zhang E; Shi J; Li X; Zhou K; Zhang Q; Le AD; Tang X
Cancer Chemother Pharmacol; 2013 Mar; 71(3):713-25. PubMed ID: 23292117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
